daily californian logo

BERKELEY'S NEWS • JANUARY 17, 2023

Year! Review! Read our 2022 Year in Retrospect Issue!

UC Berkeley, UCSF, British pharmaceutical company to collaborate on CRISPR research lab

article image

SUPPORT OUR NONPROFIT NEWSROOM

We're an independent student-run newspaper, and need your support to maintain our coverage.

|

Staff

JUNE 19, 2019

British multinational corporation GlaxoSmithKline, or GSK, announced its partnership with UC Berkeley and UCSF on June 13 to build a state-of-the-art laboratory for CRISPR research, a revolutionary genetic modification technology.

This partnership between GSK, one of the largest pharmaceutical companies in the world, UC Berkeley and UCSF will last for five years, according to the press release. Its goal is to learn more about genetics while creating future standard practices for the pharmaceutical industry.

“Technology is key to our innovation strategy at GSK, and CRISPR is one of the most important technologies of our time,” said Hal Barron, chief scientific officer and president of GSK, in the press release. “I am confident the lab will significantly advance our scientific understanding of the relationship between genes and disease to help find better medicines faster.”

According to the press release, the lab, which will be called the Laboratory for Genomic Research, or LGR, will be built near the UCSF Mission Bay campus in San Francisco and will be a novel example of industrial and academic researchers working both independently and collaboratively. GSK will provide up to $67 million in funding for LGR, including funds for facilities, 24 full-time UC employees and 14 full-time GSK employees.

LGR plans to automate current CRISPR methods and use artificial intelligence to find connections between gene variants and diseases, which will help select the most ideal patients for clinical trials, hastening drug development. According to the press release, a joint steering committee representing both UC and GSK will govern the collaboration. The committee will include Jennifer Doudna, campus professor of molecular and cell biology and chemistry and co-creator of CRISPR, as well as Jonathan Weissman, UCSF professor of cellular and molecular pharmacology, the press release said.

“Over the last seven years, CRISPR has transformed academic research, but until the LGR, we haven’t had a focused effort to catalyze the kind of research we know will lead to new innovation using this CRISPR tool,” Doudna said in the press release.I think we’re going to be able to do science that none of us can even imagine today.”

Contact Yao Huang at [email protected] and follow him on Twitter at @Yhoneplus.
LAST UPDATED

JUNE 20, 2019


Related Articles

featured article
Channel your inner SoCal kid and take this quiz to find out which summer shoe you are.
Channel your inner SoCal kid and take this quiz to find out which summer shoe you are.
featured article
featured article
The Bears haven’t won in nearly two months and are currently riding a historically atrocious 13-game losing streak. While the tides haven’t completely changed, they’re moving in the right direction.
The Bears haven’t won in nearly two months and are currently riding a historically atrocious 13-game losing streak. While the tides haven’t completely changed, they’re moving in the right direction.
featured article
featured article
Players get to make their own choices regarding their international representation, but how much of that choice is due to the inequitable centralization of resources in wealthier countries?
Players get to make their own choices regarding their international representation, but how much of that choice is due to the inequitable centralization of resources in wealthier countries?
featured article